Form 4: Maravai LifeSciences Holdings General Counsel Kurt Oreshack Reports Stock Transaction

Sentiment:

SEC Form 4 Filing


Kurt Oreshack, General Counsel of Maravai LifeSciences Holdings, reports the disposal of 4,551 shares of Class A Common Stock to cover tax obligations related to vesting restricted stock units.

Summary

  • On March 15, 2024, Kurt Oreshack, the General Counsel of Maravai LifeSciences Holdings, disposed of 4,551 shares of Class A Common Stock.
  • The transaction was executed to satisfy tax withholding obligations related to the vesting of restricted stock unit awards.
  • The price per share was $7.7.
  • Following the transaction, Oreshack directly owns 223,349 shares of Class A Common Stock.

Sentiment

Score: 5

Explanation: This is a routine transaction related to tax obligations, so it doesn't significantly impact sentiment.

Industry Context

Form 4 filings are a routine part of insider trading regulations, providing transparency into the transactions of company insiders. This transaction is related to tax obligations from vested stock, which is a common occurrence.

Stakeholder Impact

  • The transaction has a minimal impact on stakeholders as it is a routine sale to cover tax obligations.

Key Dates

DateDescription
03/15/2024Date of stock transaction
03/18/2024Date of signature on the report

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.